Navigation Links
Gender hormones may lend to social disorder therapies

Madison, Wis. -- Gender politics aside, every biologist knows that men and women truly are different.

Social disorders such as autism constitute one area where those differences come to the fore: around 80 percent of all autism cases, for example, occur in men. Social play behaviors also differ greatly between the sexes - just about everyone agrees that young boys play "rougher" th......

Full article >>> quently as the males after reaching juvenile age. The estrogen effectively "masculinized" the females, Auger says.

To the scientists' surprise, a similar result took place when they treated the females with a mimic of the neurotransmitter dopamine, a chemical messenger in the brain that regulates emotions and feelings of pleasure.

The UW-Madison study results imply that many fac......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 08/24/05


Related biology technology :

1. A social event for technology entrepreneurs
2. Changing perspectives on social networks
3. ZyStor to exhibit cell disorder treatments
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... 2016  In the pharmaceutical industry the medical affairs ... launch activities including the identification and engagement of key ... especially high in the oncology therapeutic area where most ... the Role of Medical Affairs in Oncology Launch Excellence ... therapies find better ways to utilize medical affairs to ...
(Date:2/5/2016)... -- Amarantus BioScience Holdings, Inc. ... products for Regenerative Medicine, Neurology and Orphan Diseases, announced ... from the US Food and Drug Administration (FDA) for ... granted orphan drug designation (ODD) by the US FDA ... Inc. (OTCQB: AMBS), a biotechnology company ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... compliance training, today announced an interactive FDA compliance training course, ... (Regulatory Affairs Professional Society) accredited interactive course on Morf Playbook—now conveniently available on ...
(Date:2/4/2016)...  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), the ... Edward Lanphier , Sangamo,s president and chief executive officer, ... ZFP Therapeutic ® development programs and an overview ... on Thursday, February 11, 2016, at the Leerink Partners ... is being held in New York ...
Breaking Biology Technology:
(Date:2/3/2016)... 2016 --> --> Fourth ... (105.0), up 1,187% compared with fourth quarter of 2014. Gross ... M (loss: 30.0). Earnings per share increased to SEK 6.39 ... M (neg: 74.7). , --> ... SEK 2,900.5 M (233.6), up 1,142% compared with 2014. Gross ...
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... 2, 2016 Checkpoint Inhibitors for Cancer ... Are you interested in the future of ... checkpoint inhibitors. Visiongain,s report gives those predictions to ... national level. Avoid falling behind in data ... and revenues those emerging cancer therapies can achieve. ...
Breaking Biology News(10 mins):